BRCA1 / BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients

ConclusionsBRCA1 germline mutations is associated with greater acute hematological toxicity in breast cancer patients. These observations could have implication for primary prophylaxis with G-CSF.

Source: Breast Cancer Research and Treatment - January 11, 2019 Category: Cancer & Oncology Source Type: research